Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Head & Neck 3Genitourinary 2Tumor-Agnostic 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Follicular 1Depressive Disorder, Major 1Bipolar Disorder 1

Interventions

Rituximab 1401Cyclophosphamide 1306Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 470Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 261ibrutinib 258obinutuzumab 236Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venlafaxine Hydrochloride × Lymphoid × Clear all
NCT06131268 2023-11-14

RONIN

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 4 Unknown
30 enrolled
Lymphoid

Bipolar Disorder, Depressive Disorder, Major, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡